Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Journal of Translational Medicine|February 16, 2021
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access programGiovanni Grignani, Vanna Chiarion Sileni, Carmine Pinto, et al.Journal for Immunotherapy of Cancer|August 12, 2025
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201)Giovanni Grignani, Piotr Rutkowski, Céleste Lebbé, et al.Cancers|April 13, 2023
The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN StudyMichele Del Vecchio, Vanna Chiarion Sileni, Pietro Quaglino, et al.NPJ Precision Oncology|October 28, 2021
GD2 CAR T cells against human glioblastomaMalvina Prapa, Chiara Chiavelli, Giulia Golinelli, et al.Neuro-Oncology|March 13, 2015
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE studyL Burt Nabors, Karen L Fink, Tom Mikkelsen, et al.Cancers|June 2, 2021
A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Individual Patient Program (DESCRIBE III)Victoria G Atkinson, Pietro Quaglino, Massimo Aglietta, et al.Nature Communications|March 16, 2021
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapySara De Biasi, Lara Gibellini, Domenico Lo Tartaro, et al.Journal of Neuro-Oncology|March 5, 2016
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective studyEnrico Franceschi, Roberta Depenni, Alexandro Paccapelo, et al.Journal of Neuro-Oncology|November 11, 2017
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective studyEnrico Franceschi, Roberta Depenni, Alexandro Paccapelo, et al.Critical Reviews in Oncology/Hematology|June 4, 2026
Brain tumor susceptibility: from genetic predisposition syndromes to extended characterization of genomic determinantsMarta Aprile, Vanessa Callegari, Selene Cipri, et al.Pageof 6